High temperature hyperthermia treatment for canines exhibiting superficial tumors: A report of three cases

Takagi,Hidefumi; Azuma,Kazuo; Osaki,Tomohiro; Itoh,Norihiko; Nakazumi,Shinichi; Taura,Yasuho; Okamoto,Yoshiharu

doi:10.3892/ol.2014.2496

High temperature hyperthermia treatment for canines exhibiting superficial tumors: A report of three cases

Authors:
- Hidefumi Takagi
- Kazuo Azuma
- Tomohiro Osaki
- Norihiko Itoh
- Shinichi Nakazumi
- Yasuho Taura
- Yoshiharu Okamoto
View Affiliations

Affiliations: Department of Clinical Veterinary Science, The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi 753‑8515, Japan, Department of Veterinary Clinical Science, School of Veterinary Medicine, Faculty of Agriculture, Tottori University, Tottori 680‑8533, Japan, Department of Veterinary Clinical Science, School of Veterinary Medicine, Faculty of Agriculture, Tottori University, Tottori 680‑8533, Japan, Department of Veterinary Clinical Science, School of Veterinary Medicine, Faculty of Agriculture, Tottori University, Tottori 680‑8533, Japan, AdMeTech Co., Ltd, Matsuyama 790‑0054, Japan, Department of Clinical Veterinary Science, The United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi 753‑8515, Japan
Published online on: September 3, 2014 https://doi.org/10.3892/ol.2014.2496
Pages: 2055-2058

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

High temperature hyperthermia (HTH) treatment has previously been demonstrated to suppress tumor growth in a tumor‑bearing rat model. In the present study, the effects of HTH therapy for the treatment of spontaneous tumors in canines was evaluated. In case 1, an 18‑year‑old female Papillon presented with a right forelimb rhabdomyosarcoma. Case 2 was a 13‑year‑old male English Cocker Spaniel with a right external auditory canal ceruminous adenocarcinoma and case 3 was a 14‑year‑old male Golden Retriever that exhibited a perianal gland adenocarcinoma, which surrounded the anus. HTH treatment was performed in all three cases for 10 min at 45‑65˚C with or without the inhalation of isoflurane. In case 1, the tumor disappeared four weeks following HTH treatment. In case 2, the tumor volume had decreased by day 21, and in case 3, HTH was performed three times and the tumor disappeared following the third procedure. HTH is considered to be a simple procedure with no severe side effects. Consequently, this treatment modality is hypothesized to become a useful alternative therapy for superficial tumors in companion animals.

View Figures

View References

1	Soares PI, Ferreira IM, Igreja RA, Novo CM and Borges JP: Application of hyperthermia for cancer treatment: recent patents review. Recent Pat Anticancer Drug Discov. 7:64–73. 2012.
2	Wust P, Hildebrandt B, Sreenivasa G, et al: Hyperthermia in combined treatment of cancer. Lancet Oncol. 3:487–497. 2002.
3	Falk MH and Issels RD: Hyperthermia in oncology. Int J Hyperthermia. 17:1–18. 2001.
4	Ross MI: Current status of hyperthermic limb perfusion for in-transit melanoma. Int J Hyperthermia. 24:205–217. 2008.
5	Pennacchioli E, Fiore M and Gronchi A: Hyperthermia as an adjunctive treatment for soft-tissue sarcoma. Expert Rev Anticancer Ther. 9:199–210. 2009.
6	Brewer WG Jr and Turrel JM: Radiotherapy and hyperthermia in the treatment of fibrosarcomas in the dog. J Am Vet Med Assoc. 181:146–150. 1982.
7	Page RL and Thrall DE: Clinical indications and applications of radiotherapy and hyperthermia in veterinary oncology. Vet Clin North Am Small Anim Pract. 20:1075–1092. 1990.
8	Gillette EL: Hyperthermia effects in animals with spontaneous tumors. Natl Cancer Inst Monogr. 61:361–364. 1982.
9	Grier RL, Brewer WG Jr and Theilen GH: Hyperthermic treatment of superficial tumors in cats and dogs. J Am Vet Med Assoc. 177:227–233. 1980.
10	Stojkovic R and Radacic M: Cell killing of melanoma B16 in vivo by hyperthermia and cytotoxins. Int J Hyperthermia. 18:62–71. 2002.
11	Ito A, Fujioka M, Yoshida T, et al: 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci. 98:424–430. 2007.
12	Haen SP, Pereira PL, Salih HR, Rammensee HG and Gouttefangeas C: More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol. 2011:1602502011.
13	Takagi H, Azuma K, Tsuka T, Imagawa T, Osaki T and Okamoto Y: Anti-tumor effects of high-temperature hyperthermia on a glioma rat model. Oncol Lett. 7:1007–1010. 2014.
14	Baisi A, De Simone M, Raveglia F and Cioffi U: Thermal ablation in the treatment of lung cancer: present and future. Eur J Cardiothorac Surg. 43:683–686. 2013.
15	Diederich CJ: Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation. Int J Hyperthermia. 21:745–753. 2005.
16	Roti Roti JL: Cellular responses to hyperthermia (40–46 degrees C): cell killing and molecular events. Int J Hyperthermia. 24:3–15. 2008.
17	den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ and Adema GJ: In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 64:4024–4029. 2004.
18	Baronzio G, Gramaglia A and Fiorentini G: Hyperthermia and immunity. A brief overview. In Vivo. 20:689–695. 2006.
19	Zerbini A, Pilli M, Penna A, et al: Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res. 66:1139–1146. 2006.
20	Mukhopadhaya A, Mendecki J, Dong X, et al: Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Cancer Res. 67:7798–7806. 2007.
21	Zhang HG, Mehta K, Cohen P and Guha C: Hyperthermia on immune regulation: a temperature’s story. Cancer Lett. 271:191–204. 2008.
22	Moroz P, Jones SK and Gray BN: Magnetically mediated hyperthermia: current status and future directions. Int J Hyperthermia. 18:267–284. 2002.
23	Wiggermann P, Puls R, Vasilj A, Sieroń D, Schreyer AG, Jung EM, Wawrzynek W and Stroszczynski C: Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival. Med Sci Monit. 18:CR88–CR92. 2012.